주식/증권 ➡️ 중립 GoodRx raises 2026 outlook to $765M-$785M revenue and at least $235M adjusted EBITDA, led by Pharma Direct Seeking Alpha - Market News 2026/05/08 04:54:02 1회 원문 기사 보기